Tom Bumol

Tom Bumol is a seasoned biopharmaceutical executive with extensive experience in the biotech and immunology fields. Currently serving on the Board of Directors for Tentarix Biotherapeutics, Spine BioPharma, and Omeros Corporation, as well as the Scientific Advisory Boards for CytoReason, Neurocrine Biosciences, and ProFound Therapeutics, Bumol has played a pivotal role in steering innovations within these organizations. Prior to these roles, Bumol was the Executive Vice President at the Allen Institute for Immunology and a Senior Vice President at Eli Lilly, where a career spanned over 35 years, including leadership positions at the Lilly Biotechnology Center. Academic credentials include a PhD in Microbiology and Immunology from the University of Minnesota and a BS in the same field from the University of Michigan.